THE CARLTON Football Club is excited to welcome wheezo, a Respiri product, to the Carlton family as an official AFLW partner for the 2021 season.

wheezo is a new solution developed in Australia, to assist with asthma management

02:16

Hammans' Navy Blue surprise

New recruit Charlotte Hammans had a special guest join her first interview in Navy Blue.

 

The easy to use smart-device and eHealth app allows asthma patients to record breath sounds, wheeze measurements, symptoms, triggers, medication use, location-specific weather conditions and importantly their asthma action plan.

wheezo is currently offering a nation-wide free product trial for people already diagnosed with asthma. 

To find out more click here for more information and how to join the free product trial.

The decision by wheezo to partner with the Blues’ AFLW program is backed by the company’s commitment to supporting women’s sport and improving health outcomes. 

“We are excited to partner with Carlton Football Club and their AFLW team which has an established community presence and shared health and wellness values,” Respiri’s CEO Marjan Mikel said.

02:44

Plane celebrating her culture

Nat Plane spoke on what 2020 Sir Doug Nicholls round means to her as a Kamilaroi woman.

 

Blues CEO Cain Liddle welcomed wheezo, who will be supporting the Game Changers right throughout the 2021 season.

“wheezo really want to make a difference in the world and their philosophy as a company perfectly aligns with our AFLW program,” Liddle said. 

“Their commitment to partner with our Game Changers is really exciting given their genuine interest in helping to grow women’s football.

“We look forward to having them as a significant partner for our football club moving forward.”

 

 

 

™ wheezo is a trademark of Respiri Limited. 

ABOUT RESPIRI LIMITED

Respiri is an e-Health SaaS company supporting respiratory health management. Its world-first technology detects wheeze, a typical symptom of asthma, COPD and respiratory disease to provide an objective measure of airway limitation.  wheezo, Respiri's innovative technology, comprises an eHealth app combined with a simple, easy to use, handheld device.  wheezo is the first smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use.  The asthma management platform also facilitates the sharing of data with caregivers, physicians and other health care professionals. 

Respiri’s mission is to help improve the quality of life for hundreds of millions of children and adults around the world.  Respiri Limited's operations are based in Melbourne, Australia.